DAG1 Recombinant Protein
Source : Escherichia Coli. DAG1 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain (a.a 30-312) containing 293 amino acids including a 10 a.a N-terminal His tag. The total molecular mass is 31.87kDa (calculated) . Dystroglycan 1 (DAG1) is a laminin binding component of the dystrophin-glycoprotein complex which provides a connection between the subsarcolemmal cytoskeleton and the extracellular matrix. The N-terminal domain of alpha-dystroglycan is secreted into the cerebrospinal fluid. The effect of DAG1 on the nervous system remains vague. The complete dystroglycan complex is expressed in a various tissues and has a role in processes such as laminin and basement membrane assembly, sarcolemmal stability, cell survival, peripheral nerve myelination, nodal structure, cell migration, and epithelial polarization. DAG1 is a candidate gene for the site of the mutation in autosomal recessive muscular dystrophies. The dramatic decrease of DAG1 in Duchenne muscular dystrophy leads to a loss of linkage between the sarcolemma and extracellular matrix, making muscle fibers more susceptible to necrosis.
Product Specifications
Product Name Alternative
Dystroglycan||Dystrophin-associated glycoprotein 1||DAG1||A3a||DAG||AGRNR||156DAG||MDDGC7||MDDGC9.
Purification
Greater than 90.0% as determined by SDS-PAGE.
Components
DAG1 filtered (0.4μm) and lyophilized from 0.5mg/mL in 0.05M phosphate buffer and 0.075M NaCl, pH 7.4.
Storage Conditions
Applications Notes
Amino Acids
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items